IDND Financials 07/16/2014 07:35:18 International

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
IDND Financials 07/16/2014 07:35:18
International Dispensing Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Mar 31, 2012 Dec 31, 2011
Total Revenue 466 419 107 470
Cost of Revenue 505 412 104 503
Gross Profit (39) 8 3 (33)
Operating Expenses
Research and Development 113 379 - -
Sales, General and Admin. 1,790 1,491 372 1,613
Non-Recurring Items - - - -
Other 178 228 62 258
Operating Income (2,121) (2,090) (431) (1,904)
Income From Continuing Operations
Add'l Income/Expense Items 2,800 - - -
Earnings Before Interest and Tax 679 (2,090) (431) (1,904)
Interest Expense 84 73 17 66
Earnings Before Tax 595 (2,163) (448) (1,970)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 595 (2,163) (448) (1,970)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 595 (2,163) (448) (1,970)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 595 (2,163) (448) (1,970)

Intl Dispensing Corp (IDND) Stock Research Links

IDND Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading